1 2 Why should I lose time to send a report of adverse drug reactions?

Slides:



Advertisements
Similar presentations
Warfarin, Insulin and Digoxin are the most Dangerous drugs in the elderly. Do we believe that?
Advertisements

The management of adverse drug reactions I Ralph Edwards
Walsall Healthcare NHS Trust Medicines Management.
Table 1: Top five examples of PIP according to the STOPP criteria
The Value of Medication Therapy Management Services
OBJECTIVES To examine the prevalence of potentially inappropriate medication use (PIMs) among community-dwelling older adults in a managed care organization.
PICO Presentation July 29, 2011 Jaclyn Wakita Pharmacy Resident University Hospital of Northern British Columbia.
ADVERSE DRUG REACTIONS Mary Teeling 27 April 2009.
The Nature of Errors Richard M. Satava, MD FACS Professor of Surgery University of Washington School of Medicine and Program Manager, Advanced Biomedical.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
An ABC of Drug-Related Problems RHB Meyboom, M Lindquist, ACG Egberts Drug Safety 2000;22:
Clinical Pharmacy Basma Y. Kentab MSc..
Safer Medication & Medical Devices Medication Safety & Hospital Admissions Avoidance 30 th June 2015 Dr Ahmed Ameer Medication Safety.
Drug safety in the elderly EFNS Stockholm 2012 Barbro Westerholm Prof.em, Member of Swedish Parliament.
 Pharmacovigilance – Patient’s standpoint Steve Arlington May 2007.
Requirements of EU pharmacovigilance legislation for distributors Julia Sipos Quality Management Director Pharmacovigilance coordinator Version 03.
1 Karolinska University Hospital. –Presentation Heikki Teriö, FoU-manager Education:Applied Physics and Electronics Linkoping University of Technology.
1 Establishing a Pharmacovigilance Centre Sten Olsson the Uppsala Monitoring Centre.
Pharmaco igilance Mukesh Dheda Byte Conference Centre 19 Jun 2009.
Nadja Jastrebova Pharmacovigilance Consulting Global Services Section
Clinical causality assessment I. Ralph Edwards R.H.B Meyboom.
MCA Risk:benefit analysis of Kava-kava Update as at 12 Feb 2002.
H. Lundbeck A/S21-Sep-151 Pharmacovigilance during clinical development SAE reporting, ASUR and PSUR IFF Seminar, 21. February 2007.
The Value of Medication Therapy Management Services.
ADVERSE EFFECTS OF DRUGS Phase II May Adverse Drug Reaction An adverse reaction to a drug is a harmful or unintended response. ADRs are claimed.
PHARMACOVIGILANCE AND CLINICAL TRIALS DIVISION 20 August 2015 Victoria Falls Protecting Your Right to Quality Medicines and Medical Devices.
Reporting of Adverse Drug Reactions: a study among Clinicians
ICH V2 An FDA Update Susan Lu Office of Drug Safety Center for Drug Evaluation and Research FDA January 21, 2003.
P HARMACOVIGILANCE IN P UBLIC H EALTH P ROGRAMME Dr.Sumedh M.Gaikwad MD,DM Clinical Pharmacology, Director Medical Services, Richter Themis Medicare Ltd.
Some Perspectives on a Draft Pharmacovigilance Protocol-reference to HIV/AIDS I Ralph Edwards.
CTD, Safety Tanja Braakman Genzyme Europe BV Pharmacovigilance Department.
WORD GOD END’S WITH ALPHABET "D“ WORD DRUG END’S WITH ALPHABET "G"
Sten Olsson WHO Programme Expert Uppsala Monitoring Centre Sweden
Medication Safety and admissions avoidance: A perspective Steve Williams Consultant Pharmacist in Medicine & Medication Safety Honorary Clinical Lecturer,
Medicines optimisation – a research pharmacist’s perspective Dr David Alldred Senior Lecturer in Pharmacy Practice 23 January 2015Bradford School of Pharmacy1.
METHODS TO STUDY DRUG SAFETY PROBLEMS animal experiments clinical trials epidemiological methods –spontaneous reporting case reports case series –Post-Marketing.
Definitions. Clinical pharmacy is the branch of Pharmacy where pharmacists provide patient care that optimizes the use of medication and promotes health,
Dr Shanthi Pal Quality Assurance and Safety of Medicines WHO
Controlling “Polypharmacy” in the elderly The “Medication Appropriateness Index” G. Vital-Durand 1, F. Herrmann 2, J-P. Michel 2, V. Rollason 3, N. Vogt.
What pharmacovigilance can do for you! relationship assessment is a better concept 24 Nov Dar es Salaam.
Signal identification and development I.Ralph Edwards.
Dr Mary Couper Quality Assurance and Safety of Medicines WHO
Pharmacovigilance WHO definition
Minimum requirements for Pharmacovigilance in countries.
Postmarketing Pharmacovigilance Practice at FDA Lanh Green, Pharm.D., M.P.H. Office of Surveillance and Epidemiology June 21, 2006.
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
European Patients’ Academy on Therapeutic Innovation Introduction to pharmacovigilance Monitoring the safety of medicines.
PHARMACOVIGILANCE PLAN FOR TANZANIA PREPARED BY EMMA & MARY 10 TH SEPTEMBER 2004.
Applying New Science to Drug Safety Janet Woodcock, M.D. Acting Deputy Commissioner for Operations April 15, 2005.
1 ADVERSE DRUG REACTION REPORTING AND MONITORING SOFTWARE.
Terry McInnis, MD MPH President- Blue Thorn, Inc - Mobile Co-Chair- Center for.
TLCTLC TLCTLC LTCLTC LTCLTC Delaware Valley Geriatric Education Center When Wrong Things Happen with Medications: Risk and Prevention by Donna Miller,
Medicines Act: Pharmacovigilance and the Medical Profession.
1 Pharmacovigilance & the New National Adverse Drug Reaction (ADR) Reporting System Michael Bonett, Quality Assessor Post-Licensing Directorate Medicines.
Timing of Post-discharge Venous Thromboembolic Events and Effect of Pharmacologic Prophylaxis in Hospitalized Patients Paul J. Grant MD, Todd Greene PhD,
Detection & monitoring of ADR
Efficacy and Safety of Medicines
8. Causality assessment:
3. Key definitions Multi-partner training package on active TB drug safety monitoring and management (aDSM) July 2016.
Pharmacovigilance Dr. SURENDRA.S.AKASH MD.
9. Introduction to signal detection
Quality Assurance and Safety of Medicines
Developing pharmacovigilance: new challenges and opportunities Mary Couper and Shanthi Pal Quality Assurance and Safety of Medicines.
Pharmacovigilance (PV)
68.3 million errors (28% of total) cause moderate or serious harm
Medicines Safety Mary R. Couper
Quality Assurance and Safety of Medicines
Pharmaceutical care plans Ola Ali Nassr
CPOE Medication errors resulting in preventable ADEs most commonly occur at the prescribing stage. Bobb A, et al. The epidemiology of prescribing errors:
Pharmacovigilance.
Presentation transcript:

1

2 Why should I lose time to send a report of adverse drug reactions?

3 The voluntary ADR reporting was developed to detect rare, serious, unexpected adverse drug, mainly type B, reactions over 40 years ago.

4

5 A response to a drug that is noxious and unintended and occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for modification of physiological function WHO, 1972 What is an adverse drug reaction?

6 Pharmacovigilance Monitoring and analysis of spontaneous adverse drug reactions WHO-CC: Uppsala Monitoring Centre, Sweden

7 WHO-CC Uppsala Monitoring Centre Collects volountary reports of Adveres Drug Reactions from all over the world

8 WHO Drug Monitoring Programme

9 WHO – WHO Collaborating Centre for International Drug Monitoring - The Uppsala Monitoring Centre > 4 million reports

10 SWEDIS Swedish Drug Information System ADR reports with causality assessment

11 Southern Region Lund and Malmö Northern Region Umeå Uppsala Region Uppsala Stockholm Region Stockholm Western Region Gothenburg South-east Region Linköping Six Health Care Regions - each with a medical school

12

13 Causality Assessment Known reaction Time-relasionship Cannot be explained by the underlying diseases or medications

14 I stopped taking the medicine because I prefer the original disease to the side effects !

15 Causality Assessment Known reaction Time-relasionship Cannot be explained by the underlying diseases or medications Dissapperar at dechallenge Reappear at Rechallenge

16 ADR reports in Sweden

17

18

19 Pharmacovigilance from a public health point of view

20 Bergman U, Wiholm B-E. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol 1981;20:

21

22

23 Bergman U, Wiholm B-E. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol 1981;20: Von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records and thereby indicate the quality of drug utilisation. Pharmacoepidemiol Drug Safe 2006;15:

24

25 Swedish ADR hospitalization studies 1. Beermann B, Biörck G, Groshinsky-Grind M. Läkemedelsbiverkningar och intoxikationer som orsak till intagning på invärtesmedicinsk klinik. Läkartidningen 1978;75: Bergman U, Wiholm B-E. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol 1981;20: Sarlöv C, Andersén-Karlsson E, von Bahr C. Läkemedelsbiverkningar leder till sjukhusvård för hjärtpatienter. Läkartidningen 2001;47: Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm B-E, Wahlin A et al. Adverse drug reaction as a cause for admissions to a department of internal medicine. Pharmacoepidemol Drug Safe 2002;11: Von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records and thereby indicate the quality of drug utilisation. Pharmacoepidemiol Drug Safe 2006;15:

26 ADR hospitalizations in % 1.Beermann B, Biörck G, Groshinsky-Grind M. Läkemedelsbiverkningar och intoxikationer som orsak till intagning på invärtesmedicinsk klinik. 9 % Läkartidningen 1978;75: Bergman U, Wiholm B-E. Drug-related problems causing admission 6 % to a medical clinic. Eur J Clin Pharmacol 1981;20: Sarlöv C, Andersén-Karlsson E, von Bahr C. Läkemedelsbiverkningar 14 % leder till sjukhusvård för hjärtpatienter. Läkartidningen 2001;47: Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm B-E, Wahlin A. Adverse drug reaction as a cause for admissions to a department of internal 12 % medicine. Pharmacoepidemol Drug Safe 2002;11: Von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records 11 % and thereby indicate the quality of drug utilisation. Pharmacoepidemiol Drug Safe 2006;15:

27 Mean AGE in ADR hospitalizations 1.Beermann B, Biörck G, Groshinsky-Grind M. Läkemedelsbiverkningar och intoxikationer som orsak till intagning på invärtesmedicinsk klinik. 71 year Läkartidningen 1978;75: Bergman U, Wiholm B-E. Drug-related problems causing admission 66 year to a medical clinic. Eur J Clin Pharmacol 1981;20: Sarlöv C, Andersén-Karlsson E, von Bahr C. Läkemedelsbiverkningar 77 year leder till sjukhusvård för hjärtpatienter. Läkartidningen 2001;47: Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm B-E, Wahlin A. Adverse drug reaction as a cause for admissions to a department of internal 74 year medicine. Pharmacoepidemol Drug Safe 2002;11: Von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records 72 year and thereby indicate the quality of drug utilisation. Pharmacoepidemiol Drug Safe 2006;15:

28 Number of drugs/patient with ADR hospitalizations 1.Beermann B, Biörck G, Groshinsky-Grind M. Läkemedelsbiverkningar och intoxikationer som orsak till intagning på invärtesmedicinsk klinik. 3,7 Läkartidningen 1978;75: Bergman U, Wiholm B-E. Drug-related problems causing admission 3,5 to a medical clinic. Eur J Clin Pharmacol 1981;20: Sarlöv C, Andersén-Karlsson E, von Bahr C. Läkemedelsbiverkningar 6,2 leder till sjukhusvård för hjärtpatienter. Läkartidningen 2001;47: Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm B-E, Wahlin A. Adverse drug reaction as a cause for admissions to a department of internal 7 medicine. Pharmacoepidemol Drug Safe 2002;11: Von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records 8,3 and thereby indicate the quality of drug utilisation. Pharmacoepidemiol Drug Safe 2006;15:

29 % phararmacological (typ A) ADRs 1.Beermann B, Biörck G, Groshinsky-Grind M. Läkemedelsbiverkningar och intoxikationer som orsak till intagning på invärtesmedicinsk klinik. >75 % Läkartidningen 1978;75: Bergman U, Wiholm B-E. Drug-related problems causing admission >75 % to a medical clinic. Eur J Clin Pharmacol 1981;20: Sarlöv C, Andersén-Karlsson E, von Bahr C. Läkemedelsbiverkningar 100 % leder till sjukhusvård för hjärtpatienter. Läkartidningen 2001;47: Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm B-E, Wahlin A. Adverse drug reaction as a cause for admissions to a department of internal 91 % medicine. Pharmacoepidemol Drug Safe 2002;11: Von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records 89 % and thereby indicate the quality of drug utilisation. Pharmacoepidemiol Drug Safe 2006;15:

30

31 In summary: ADRs in 2000 vs 1970s % more ADR hospitalizations More elderly patients More drugs per patient Pharmacologcal reactions (type A) dominats completely

32 Adverse drug reactions as cause of admission to hospital: prospective analysis of patients. British Medical Journal 2004;329;15-9 Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Kevin Park B and Breckenridge AM.

33 Types of ADRs –Type A Predictable from pharmacology of the drug, dose-dependent and preventable – 95%  Type B Bizzare, unpredictable from known pharmacology, and no dose-dependency — 5% Pirmohamed M. et al. Br Med J 329:15-19 (2004)

34 Types of ADRs –Type A Predictable from pharmacology of the drug, dose-dependent and preventable – 95%  Type B Bizzare, unpredictable from known pharmacology, and no dose-dependency — 5% ____________________________________ – 76% of patients were 65 years or over Pirmohamed M. et al. Br Med J 329:15-19 (2004)

35 How Many ADRs Were Avoidable? Definitely avoidable 8.6% Possibly avoidable 63.1% Not avoidable 28.1% 72 % of ADRs were definitely or possibly avoidable –Pirmohamed M. et al. Br Med J 329:15-19 (2004)

36 Importance for Health care provider Industry and Regulatory Agency Type A Type B Adverse Drug Reactions

37 Keep in mind the origin –Advancement in safety heavily relies on reporting of safety events by health care professionals

38 Take Home messages: Adverse Drug Reactions- ADRs Spontaneous ADR monitoring is basis for Pharmacovigilance Pharmacological ADRs is a matter for the local health care provider – quality of care An area for Clinical Pharmacology

39 Take Home messages: Adverse Drug Reaction- a Differential diagnosis An ADR diagnosis: (a minimum an ICD-10 Y 57.9 Ogynnsam effekt av drog eller läkemedel i terapeutiskt bru Submitt an ADR report

40 Thank you for staying till the end!

41 Time for Questions & Answeres If you don ’ t ask stupid question You remain stupid Alvan Feinstein

42 Pharmacovigilance The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. Source: The Importance of Pharmacovigilance, WHO 2002

43 Causality Assessment Certain Probable Possible Unlikely Unclassifiable